|
[1]
|
Zhang, M., Xu, X., Su, L., Zeng, Y., Lin, J., Li, W., et al. (2024) Oral Administration of Sophora flavescens-Derived Exosomes-Like Nanovesicles Carrying CX5461 Ameliorates DSS-Induced Colitis in Mice. Journal of Nanobiotechnology, 22, Article No. 607. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Wu, T., Bai, X., Zhang, Y., Dai, E., Ma, J., Yu, C., et al. (2024) Natural Medicines-Derived Carbon Dots as Novel Oral Antioxidant Administration Strategy for Ulcerative Colitis Therapy. Journal of Nanobiotechnology, 22, Article No. 511. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Shrestha, P., Duwa, R., Lee, S., Kwon, T.K., Jeong, J. and Yook, S. (2024) ROS-Responsive Thioketal Nanoparticles Delivering System for Targeted Ulcerative Colitis Therapy with Potent HDAC6 Inhibitor, Tubastatin A. European Journal of Pharmaceutical Sciences, 201, Article 106856. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Gao, C., Yang, Z., Song, R., Sheng, H. and Zhu, L. (2025) Nanotechnology-Based Drug Delivery System for Targeted Therapy of Ulcerative Colitis from Traditional Chinese Medicine: A Review. International Journal of Pharmaceutics, 673, Article 125375. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Hu, S., Zhao, R., Xu, Y., Gu, Z., Zhu, B. and Hu, J. (2024) Orally-Administered Nanomedicine Systems Targeting Colon Inflammation for the Treatment of Inflammatory Bowel Disease: Latest Advances. Journal of Materials Chemistry B, 12, 13-38. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Ardekani, Z.M., Lorenzo-Leal, A.L. and Bach, H. (2024) Nanomedicine-Mediated Drug Delivery for Potential Treatment of Inflammatory Bowel Disease: A Narrative Review. Nanomedicine, 19, 163-179. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Chen, M., Lan, H., Jin, K. and Chen, Y. (2023) Responsive Nanosystems for Targeted Therapy of Ulcerative Colitis: Current Practices and Future Perspectives. Drug Delivery, 30, Article 2219427. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Ma, L., Lyu, W., Song, Y., Chen, K., Lv, L., Yang, H., et al. (2023) Front Cover: Anti‐Inflammatory Effect of Clostridium butyricum‐Derived Extracellular Vesicles in Ulcerative Colitis: Impact on Host MicroRNAs Expressions and Gut Microbiome Profiles. Molecular Nutrition & Food Research, 67, Article 2370029. [Google Scholar] [CrossRef]
|
|
[9]
|
Sun, T., Kwong, C.H.T., Gao, C., Wei, J., Yue, L., Zhang, J., et al. (2020) Amelioration of Ulcerative Colitis via Inflammatory Regulation by Macrophage-Biomimetic Nanomedicine. Theranostics, 10, 10106-10119. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Jia, Z., Yu, M., Wang, W., Ghazimirsaeid, S., Qu, Y. and Zhang, M. (2024) An Oxidative Cleavage-Based Cruciform DNA Nanostructure for in Vivo Hypochlorous Acid Visualization to Monitor Intestinal Inflammation. Analytical Chemistry, 96, 9621-9628. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Kan, L., Zheng, Z., Fu, W., Ma, Y., Wang, W., Qian, H., et al. (2024) Recent Progress on Engineered Micro/Nanomaterials Mediated Modulation of Gut Microbiota for Treating Inflammatory Bowel Disease. Journal of Controlled Release, 370, 43-65. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Govindarasu, M., Vaiyapuri, M. and Kim, J. (2024) Protective Effect of Zinc Oxide Nanoparticles Synthesized Using Cassia alata for DSS-Induced Ulcerative Colitis in Mice Model. Bioprocess and Biosystems Engineering, 47, 1393-1407. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Gao, S., Zheng, H., Xu, S., Kong, J., Gao, F., Wang, Z., et al. (2023) Novel Natural Carrier‐Free Self‐Assembled Nanoparticles for Treatment of Ulcerative Colitis by Balancing Immune Microenvironment and Intestinal Barrier. Advanced Healthcare Materials, 12, Article 2301826. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Zhao, X., Zhang, Y., Wang, P., Liu, K., Zheng, Y., Wen, J., et al. (2024) Layer by Layer Self-Assembled Hyaluronic Acid Nanoarmor for the Treatment of Ulcerative Colitis. Journal of Nanobiotechnology, 22, Article No. 633. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Müller, E.K., Białas, N., Epple, M. and Hilger, I. (2022) Nanoparticles Carrying NF-κB P65-Specific siRNA Alleviate Colitis in Mice by Attenuating NF-κB-Related Protein Expression and Pro-Inflammatory Cellular Mediator Secretion. Pharmaceutics, 14, Article 419. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Zhang, D., Zhu, B., Xu, Y., Luo, F., Chen, T., Chen, L., et al. (2025) Oleanolic Acid-Based Nanoparticles for the Treatment of Ulcerative Colitis. Nanomedicine, 20, 677-690. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Zhou, S., Yu, Z., Yao, W., Wang, M., Yang, Y., Qin, J., et al. (2025) Pectin/Caffeic Acid Nanoparticles in a Poloxamer Thermosensitive Gel for the Treatment of Ulcerative Colitis by Inhibiting cGAS-STING Pathway. Colloids and Surfaces B: Biointerfaces, 247, Article 114419. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Xiao, J., Zhou, S., Fei, F., Long, L. and Guo, C. (2025) Pectin-Loaded Ferulic Acid Nanoparticles: A Potential Therapeutic Strategy for Ulcerative Colitis via Modulation of the cGAS-STING Pathway. Toxicology and Applied Pharmacology, 499, Article 117317. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Chi, X., Chen, T., Luo, F., Zhao, R., Li, Y., Hu, S., et al. (2024) Targeted No-Releasing L-Arginine-Induced Hesperetin Self-Assembled Nanoparticles for Ulcerative Colitis Intervention. Acta Biomaterialia, 190, 560-578. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Kumar, A., Vaiphei, K.K., Singh, N., Datta Chigurupati, S.P., Paliwal, S.R., Paliwal, R., et al. (2024) Nanomedicine for Colon-Targeted Drug Delivery: Strategies Focusing on Inflammatory Bowel Disease and Colon Cancer. Nanomedicine, 19, 1347-1368. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Motamedzadeh, A., Rahmati-Dehkordi, F., Heydari, H., Behnam, M., Rashidi Noshabad, F.Z., Tamtaji, Z., et al. (2024) Therapeutic Potential of Phycocyanin in Gastrointestinal Cancers and Related Disorders. Molecular Biology Reports, 51, Article No. 741. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Scarcello, E., Abdel-Mottaleb, M.M.A., Beduneau, A., Moulari, B. and Pellequer, Y. (2021) Amelioration of Murine Experimental Colitis Using Biocompatible Cyclosporine a Lipid Carriers. Drug Delivery and Translational Research, 11, 1301-1308. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Minakshi, P., Kumar, R., Ghosh, M., Brar, B., Barnela, M. and Lakhani, P. (2020) Application of Polymeric Nano-Materials in Management of Inflammatory Bowel Disease. Current Topics in Medicinal Chemistry, 20, 982-1008. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Ibaraki, H., Hatakeyama, N., Arima, N., Takeda, A., Seta, Y. and Kanazawa, T. (2022) Systemic Delivery of siRNA to the Colon Using Peptide Modified PEG-PCL Polymer Micelles for the Treatment of Ulcerative Colitis. European Journal of Pharmaceutics and Biopharmaceutics, 170, 170-178. [Google Scholar] [CrossRef] [PubMed]
|